Cargando…
Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30
BACKGROUND: The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with the 21-gene recurrence score (RS) of 18–30, particularly those with RS 26–30, are not known. METHODS: Using the Surveillance,...
Autores principales: | Park, Seho, Han, Yunan, Liu, Ying, Toriola, Adetunji T., Peterson, Lindsay L., Colditz, Graham A., Kim, Seung Il, Cho, Young Up, Park, Byeong-Woo, Park, Yikyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796491/ https://www.ncbi.nlm.nih.gov/pubmed/31619259 http://dx.doi.org/10.1186/s13058-019-1190-4 |
Ejemplares similares
-
Changes in adiposity over the life course and gene expression in postmenopausal women
por: Han, Yunan, et al.
Publicado: (2022) -
Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
por: Han, Yunan, et al.
Publicado: (2022) -
Determinants of Mammographic Breast Density by Race Among a Large Screening Population
por: Moore, Justin X, et al.
Publicado: (2020) -
Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients?
por: Yoon, Kwang Hyun, et al.
Publicado: (2019) -
Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?
por: Akinjiyan, Favour A., et al.
Publicado: (2021)